Dunhill Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-32
Closed -$1.09K 1020
2025
Q1
$1.09K Hold
32
﹤0.01% 796
2024
Q4
$1.26K Hold
32
﹤0.01% 742
2024
Q3
$1.5K Hold
32
﹤0.01% 754
2024
Q2
$1.73K Hold
32
﹤0.01% 587
2024
Q1
$2.18K Hold
32
﹤0.01% 473
2023
Q4
$2K Buy
+32
New +$2K ﹤0.01% 454